Cost-utility analysis of Amevive™ (alefacept) in the treatment of patients with moderate-to-severe psoriasis

被引：0
|
作者：
Iskedjian, M
Barkovsky, L
Desjardins, O
Walker, JH
Dorkalam, M
Shear, N
Einarson, TR
机构：
[1] PharmIdeas Res & Consulting Inc, Oakville, ON, Canada
[2] Brock Univ, St Catharines, ON L2S 3A1, Canada
[3] Biogen Idec Canada Inc, Mississauga, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62869-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
  • [1] A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
    Colombo, Giorgio L.
    Di Matteo, Sergio
    Peris, Ketty
    Fargnoli, Maria Concetta
    Esposito, Maria
    Mazzotta, Annamaria
    Chimenti, Sergio
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2009, 1 : 53 - 59
  • [2] A COST-UTILITY ANALYSIS OF ETANERCEPT FOR THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS IN ITALY
    Di Matteo, S.
    Colombo, G. L.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A457 - A457
  • [3] Cost-effectiveness analysis of amevivetm (Alefacept) in the treatment of patients with moderate-to-severe psoriasis
    Iskedjian, M
    Barkovsky, L
    Desjardins, O
    Walker, JH
    Dorkalam, M
    Shear, N
    Einarson, TR
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 330 - 330
  • [4] COST-UTILITY ANALYSIS OF APREMILAST FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN SPAIN
    Carrascosa, J. M.
    Vanaclocha, F.
    Caloto, T.
    Echave, M.
    Oyaguez, I
    Tencer, T.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A420 - A420
  • [5] COST-UTILITY ANALYSIS OF ADALIMUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS IN PATIENTS IN SPAIN
    Wang, S.
    Yang, H.
    Yang, M.
    Bao, Y.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A670 - A670
  • [6] Alefacept (Amevive) for treatment of psoriasis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1154): : 31 - 32
  • [7] COST-UTILITY OF USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN COLOMBIA
    Aguirre, A.
    Guerrero, E.
    Hernandez, N.
    Coronell, S.
    Argote, A. C.
    Giraldo, C., V
    Ojeda, C.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A211 - A211
  • [8] COST-UTILITY OF USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN COLOMBIA
    Ojeda, C.
    Hernandez, N.
    Giraldo, C., V
    Argote, A. C.
    Coronell, S.
    Roa, M.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A124 - A124
  • [9] Use of extended courses of alefacept in the treatment of moderate-to-severe psoriasis
    Gupta, Aditya
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB192 - AB192
  • [10] COST-UTILITY ANALYSIS OF APREMILAST FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN THE ITALIAN SETTING
    Barbieri, M.
    Capri, S.
    Oskar, B.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A419 - A420
12345